Eniola's core research (CCT addiction model) doesn't align with the Lush Prize's core mission of replacing animal testing in toxicology. While TOPOLOGIX (drug-protein interaction, hERG cardiotoxicity) has computational toxicology elements and IMPRINT touches drug screening, these are supporting platforms rather than the primary research focus. Would require substantial reframing to position as animal-replacement research.